NN Group is a financial services company based in the Netherlands. Co. engages in insurance and investment management activities, providing life and non-life insurance products primarily in the Netherlands, Belgium, rest of Europe, and Asia. Co. offers group and individual life insurance; and motor, transport, fire, liability, travel, and income insurance. Co. also offers retirement, insurance, investments, and banking services to retail, SME, corporate, and institutional customers. Co. is active in 18 countries, with a presence predominantly in a number of European countries and Japan.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
NN Group (Achat) : RN de €2 mds (+75,5%) en 2019 Teva (Achat): Table sur un cash-flow libre entre $1,8md et $2,2mds en 2020 Commerzbank (Neutre versus Vente) : RN de €644m (-25,3%) en 2019 Nexi (Achat) : RN de €223m (+18,7%) en 2019 Credit Suisse (Achat) : RN de CHF3,4mds (+69%) en 2019 Mercialys (Achat) : CAF (FFO) de €124,2m (+7,9%) en 2019 Orange (Achat hybrides) : RN de €3 mds (+54%) en 2019 Emetteurs : Aegon, Commerzbank, OPEP, Nexi, Credit Suisse, BCE, Carnival, Mercialys, Pernord Ricard, Imerys, Ipsen, Orange, BP, Ahol...
ABN Amro: 4Q CC: some positives, but slippery outlook Ahold Delhaize: Lifting estimates post FY19 reporting Arcadis: Solid 4Q19 operational performance Barco: On a sustainable profitable growth path DSM: 4Q EBITDA +3% underlying, 1% above estimates Euronext: 4Q19: Solid top line; one-offs weighing on result Fagron: Topline slightly below expectations, strong margins IO&W: FY19 Results better than expected Kinepolis: Free to open new Belgian cinemas from August’21 Montea: FY19: All targets achieved NN Group: Strong results, SBB, upgrading to BUY RELX Group: Slightly better FY results, Volatile ...
Unicredit (Achat) : Nouveau plan stratégique jusqu’en 2023 NN Group et Ageas : Pourraient acquérir l’assureur espagnol Caser Seguros Zone euro : L'indice PMI de l’industrie manufacturière se redresse à 46,9 General Electric (Achat) : Prévoit une marge opérationnelle de ~20% pour la division de santé en 2019 Sisal Pay : Emission de €530m à 7 ans à taux variable Télécoms : 21 dirigeants de groupes télécoms européens favorable à la consolidation transnationale Hema (Vente) : Moody’s dégrade la note d’un cran à Caa1, la perspective est négat...
The general evaluation of ZIX CORP. (US), a company active in the Computer Services industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 2 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date February 18, 2020, the closing price was USD 7.34 and its potential was estimated at USD 9.06.
ZAI LAB ADR.LTD. (US), a company active in the Biotechnology industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date February 18, 2020, the closing price was USD 61.10 and its potential was estimated at USD 64.16.
The independent financial analyst theScreener just lowered the general evaluation of SPIRIT AIRLINES INCO. (US), active in the Airlines industry. As regards its fundamental valuation, the title now shows 3 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date February 18, 2020, the closing price was USD 42.59 and its target price was estimated at USD 34.08.
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.